RGEN FY 2016 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2016 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$105M+25.1% YoY

Gross Profit

$57M54.9% margin

Operating Income

$16M15.3% margin

Net Income

$12M11.2% margin

EPS (Diluted)

$0.34

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$3M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$289M

Total Liabilities

$120M

Stockholders' Equity

$169M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$105M	$84M	+25.1%
Gross Profit	$57M	$48M	+18.9%
Operating Income	$16M	$14M	+16.1%
Net Income	$12M	$9M	+25.0%